UNITY Biotechnology

PharmaceuticalsSeries CBrisbane, USunitybiotechnology.com

Latest round

Series C

Last raised

Mar 2018

Total raised

$198M

Investors

18

About UNITY Biotechnology

UNITY Biotechnology, Inc.UNITY Biotechnology was founded in 2009 in Brisbane, US, by Akeem Shinholster and Nathaniel David. The company specializes in creating therapies to combat age-related health issues, notably through biologic treatments designed to eliminate senescent cells.UNITY Biotechnology is focused on developing therapeutics aimed at alleviating age-related diseases by targeting cellular senescence. The company’s core product offerings include biologic treatments designed to eliminate senescent cells implicated in various degenerative conditions. Their flagship products target significant health challenges such as osteoarthritis and retinal diseases leading to vision loss.In 2022, UNITY Biotechnology generated revenue of USD 236,000 and reported an EBITDA of USD -30,304,000. Their revenue model is structured around partnerships with pharmaceutical companies and healthcare providers, facilitating the development and commercialization of their therapeutic products. Plans include developing new therapeutics for additional age-related diseases and acquiring market shares in new geographic regions, specifically targeting European markets by 2025.

Who invested in UNITY Biotechnology

18 investors across 3 rounds

See all investors in UNITY Biotechnology

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series C

    Mar 15, 2018

    Amount

    $55M

    Investors

    Locked

  2. Series B

    Aug 17, 2017

    Amount

    $35M

    Investors

    Locked

  3. Series B

    Oct 14, 2016

    Amount

    $108M

    Investors

    Locked

Questions about UNITY Biotechnology

Who invested in UNITY Biotechnology?

UNITY Biotechnology has 18 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has UNITY Biotechnology raised?

UNITY Biotechnology has raised 3 venture rounds. Sign up free to see how much each round raised and the total.

When did UNITY Biotechnology last raise money?

UNITY Biotechnology's most recent round on record is a Series C, in Mar 2018.

What does UNITY Biotechnology do?

UNITY Biotechnology is a pharmaceuticals company.

Where is UNITY Biotechnology headquartered?

UNITY Biotechnology is headquartered in Brisbane, US.

Which VCs invest in companies like UNITY Biotechnology?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back pharmaceuticals companies at UNITY Biotechnology's stage. Their profiles are linked below.

Raising like UNITY Biotechnology? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.